Deemea

Biotechnology Research • Paris, Île-de-France, France • 21-50 Employees

Company overview

Headquarters	Paris, Île-de-France, France
Website	deemea.com
NAICS	541714
Founded	2020
Employees	21-50
Socials

Key Contacts at Deemea

Charlotte Pouchy

Chief Executive Officer

Julia Panozzo

Product Owner, Recherche Clinique, Imagerie Médicale

Deemea Email Formats

Deemea uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@deemea.com), used 57.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@deemea.com	57.7%
{first initial}.{last name}	j.doe@deemea.com	34.6%
{first initial}	j@deemea.com	7.7%

About Deemea

Deemea is a digital health company with expertise in the AI-driven structuring and analysis of medical data. Our specialization in imaging data processing has led us to develop and deploy a collaborative platform for medical data analysis, aimed at expediting biopharmaceutical and medical device clinical studies. Our innovative proprietary technology powers a multi-modal, multi-centric platform that prioritizes the security, privacy, and sovereignty of medical data, as well as the sustainability of healthcare facilities. Deemea empowers data-driven research, ultimately expediting patients' access to innovative therapies.

Deemea revenue & valuation

Annual revenue	$1,796,655
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,800,000
Total funding	$4,780,700